Antimicrobial Susceptibility Testing Market Worth $5.09 billion by 2027 at a CAGR of 6.1%, Forecast Period 2019-2027- Meticulous Research

Meticulous Research- leading global market research company published a research report titled "Antimicrobial Susceptibility Testing Market by Product (Manual Testing, Automated AST, Consumable), Method (Disk Diffusion, Dilution), Application (Clinical Diagnosis, Epidemiology), End User (Diagnostic Laboratories, Hospital) - Forecast to 2027".

According to this latest publication from Meticulous Research, the global antimicrobial susceptibility testing market is expected to grow at a CAGR of around 6.1% between 2019-2027 to reach to $5.09 billion by 2027. The growth in the overall antimicrobial susceptibility testing market is mainly attributed to the rising global incidences of infectious diseases, increased funding and government initiatives, and emergence of multidrug resistance. However, stringent government regulations are a key factor expected to hinder the adoption of antimicrobial susceptibility testing products over the coming years.

The global antimicrobial susceptibility testing market study presents historical market data in terms of values (2017 and 2018), estimated current data (2019), and forecasts for 2027- by product (manual antimicrobial susceptibility testing products, automated antimicrobial susceptibility testing products, consumable), method (disk diffusion, rapid automated AST, dilution, and other methods), application (clinical diagnosis, drug discovery & development, and other applications), end user (diagnostic laboratories, hospitals, pharma biotech industry, and research & academic institutes), and geography. The study also evaluates industry competitors and analyzes the market at the regional and country level.

Get a sample copy of the premium report: -
https://www.meticulousresearch.com/request-sample-report/cp_id=5062

Based on product type, the manual susceptibility testing products segment accounted for the largest share of the overall antimicrobial susceptibility testing market in 2019; however, automated AST products are expected to register the faster growth during the forecast period. Less time for susceptibility testing than the manual methods, higher accuracy due to minimization of the human interference, and incessant launch of newer automated devices by manufacturers are some of the key factors fueling the growth of the automated AST product market.

Based on application, the clinical diagnostics segment accounted for the largest share of the overall antimicrobial susceptibility testing market in 2019 and is also expected to register the fastest growth between 2019 and 2027. The factors such as growing awareness about the use of antimicrobial susceptibility testing methods for diagnostic applications, technological advancements in AST products for clinical diagnostic applications, rising burden of infectious diseases with antimicrobial resistance, and positive government intervention regarding early disease screening are driving the growth of this segment.

Geographically, North America commanded the largest share of the global antimicrobial susceptibility testing market in 2019, followed by Europe and Asia Pacific. The factors such as easy accessibility, increasing prevalence of antimicrobial resistance, and better adoption of technologically advanced susceptibility testing methods and products are accelerating the growth of antimicrobial susceptibility testing market in the North American region.

Download a sample report and gain crucial industry insights: -
https://www.meticulousresearch.com/download-sample-report/cp_id=5062

The key players operating in the global antimicrobial susceptibility testing market are Thermo Fisher Scientific Inc. (U.S.), Merck KGaA (Germany), Bio-Rad Laboratories, Inc. (U.S.), bioMerieux S.A. (France), Becton, Dickinson and Company (U.S.), Danaher Corporation (U.S.), HiMedia Laboratories (India), MERLIN Diagnostika GmbH (Germany), Accelerate Diagnostics, Inc. (U.S.), Alifax S.r.l. (Italy), Creative Diagnostics (U.S.), Synbiosis (U.K.), and Zhuhai DL Biotech Co., Ltd (China) among others.

Key questions answered in the report

o Which are the high growth market segments in terms of product, method, application, end-users, and region/countries?

o What was the historical market for antimicrobial susceptibility testing across the globe?

o What are the market forecasts and estimates for the period 2019-2027?

o What are the major drivers, restraints, opportunities, and challenges in the global antimicrobial susceptibility testing market?

o Who are the major players in the antimicrobial susceptibility testing market?

o How is the competitive landscape and who are the market leaders in the global antimicrobial susceptibility testing market?

o What are the recent developments in the global antimicrobial susceptibility testing market?

o What are the different strategies adopted by the major players in the global antimicrobial susceptibility testing market?

o What are the geographical trends and high growth regions/ countries?

Enquire or share your questions if any: -
https://www.meticulousresearch.com/enquire-before-buying/cp_id=5062

Table of Contents

1. Introduction

1.1. Market Definition
1.2. Market Ecosystem
1.3. Currency
1.4. Key Stakeholders

2. Research Methodology

2.1. Research Approach
2.2. Data Collection & Validation
2.2.1. Secondary Research
2.2.2. Primary Research
2.3. Market Assessment
2.3.1. Market Size Estimation
2.3.1.1. Bottom-Up Approach
2.3.1.2. Top-Down Approach
2.3.1.3. Growth Forecast
2.3.2. Market Share Analysis
2.4. Assumptions for the Study
2.5. Limitations for the Study

3. Executive Summary

4. Market Insights

4.1. Introduction
4.2. Drivers
4.2.1. Rising Prevalence of Infectious Diseases
4.2.2. Emergence of Multidrug Resistance
4.2.3. Increased Funding and Government Initiatives
4.2.4. Technological Advancements towards the Development of Rapid AST Methods
4.3. Restraint
4.3.1. Stringent Government Regulations
4.4. Opportunity
4.4.1. Growth Prospects in Emerging Markets
4.5. Challenge
4.5.1. High Cost of Automated Antimicrobial Susceptibility Testing

5. Antimicrobial Susceptibility Testing Market, by Product

5.1. Introduction
5.2. Manual Antimicrobial Susceptibility Testing Products
5.2.1. Susceptibility Disks
5.2.2. Susceptibility Plates
5.2.3. Minimum Inhibitory Concentration (MIC Strips)
5.3. Consumables
5.4. Automated Antimicrobial Susceptibility Testing Products

6. Antimicrobial Susceptibility Testing Market, by Method

6.1. Introduction
6.2. Disk Diffusion
6.3. Rapid Automated AST
6.4. Dilution
6.5. Others

7. Antimicrobial Susceptibility Testing Market, by Application

7.1. Introduction
7.2. Clinical Diagnosis
7.3. Drug Discovery and Development
7.4. Other Applications

8. Antimicrobial Susceptibility Testing Market, by End User

8.1. Introduction
8.2. Diagnostic Laboratories and Hospitals
8.3. Pharmaceutical and Biotechnology Companies
8.4. Research and Academic Institutes

9. Global Antimicrobial Susceptibility Testing Market, by Geography

9.1. Introduction
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.3. Europe
9.3.1. Germany
9.3.2. U.K.
9.3.3. France
9.3.4. Italy
9.3.5. Spain
9.3.6. Rest of Europe
9.4. Asia-Pacific
9.4.1. China
9.4.2. Japan
9.4.3. India
9.4.4. Rest of Asia-Pacific
9.5. Latin America
9.6. Middle East and Africa

.... Continued

Speak to our expert analyst: -
https://www.meticulousresearch.com/speak-to-analyst/cp_id=5062

Office Address

Asia-Pacific
Office No-202, 203,204,205,206;
2nd Floor, Pushpak Business Hub,
Wakad, Pimpri-Chinchwad,
411057, India.

Meticulous Research was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, with the help of its unique research methodologies, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa regions.

This release was published on openPR.